ASMB
Assembly Biosciences Inc
24.00$
-5.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 1.2% | 0.6% | 0.4% | 197.4% | 194.1% | 157.7% | 167.5% | 153.7% | 0.1% | 0.3% | 0.1% | 22.3% | |
| – | 98.8% | 99.4% | 99.6% | -97.4% | -94.1% | -57.7% | -67.5% | -53.7% | 99.9% | 99.7% | 99.9% | 77.7% | |
| – | 153.7% | 205.3% | 190.5% | 197.4% | 194.1% | 157.7% | 167.5% | 153.7% | 40.6% | 181.4% | 111.5% | 85.0% | |
| – | 121.6% | 80.1% | 52.5% | 62.6% | 62.6% | 47.9% | 47.7% | 47.1% | 12.8% | 57.0% | 35.9% | 26.7% | |
| – | 274.0% | 284.9% | 242.6% | 62.6% | 62.6% | 47.9% | 47.7% | 47.1% | 53.4% | 238.4% | 147.3% | 89.6% | |
| – | -175.2% | -185.5% | -143.0% | -160.1% | -156.7% | -105.5% | -115.2% | -100.9% | 46.6% | -138.4% | -47.4% | -11.8% | |
| – | -152.6% | -156.9% | -125.9% | -140.4% | -139.4% | -93.6% | -105.9% | -85.2% | 52.0% | -110.5% | -28.8% | -0.1% | |
| – | 0.5% | -0.2% | 4.8% | – | 1.0% | – | – | – | – | – | – | – | |
| – | -153.0% | -156.9% | -130.7% | -140.4% | -140.5% | -93.6% | -105.9% | -85.2% | 52.0% | -110.5% | -28.8% | -0.1% | |
| – | -151.4% | -156.4% | -125.6% | -140.0% | -139.0% | -93.3% | -105.6% | -84.9% | 52.1% | -110.2% | -28.7% | 0.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.